WHO tiedottaa:
SARS-CoV-2 reported cases: Last 28 days
In the 28-day period from 19 May 2025 to 15 June 2025, 87 countries across five WHO regions reported new COVID-19 cases. During this 28-day period, a total of 346,183 new cases were reported, which is an increase compared to the 141,796 new cases reported from 93 countries in the previous 28-day period (Table 2). Overall, 50 countries from Africa, the Americas, Europe, and South-East Asia showed an increase in new cases of over 10%.
Country level details are available in | Cases section
Table 2.1. Newly reported COVID-19 confirmed cases by WHO regions
28-days to the date| WHO Region | 18 May 2025 | 15 Jun 2025 |
|---|---|---|
| World | 141,796 | 346,183 |
| Africa | 205 | 138 |
| Americas | 11,600 | 11,065 |
| Eastern Mediterranean | No value | No value |
| Europe | 14,070 | 18,613 |
| South-East Asia | 115,885 | 316,364 |
| Western Pacific | 36 | 3 |
Table 2.2. Number of countries reported newly COVID-19 confirmed cases by WHO regions
28-days to the date| WHO Region | 18 May 2025 | 15 Jun 2025 |
|---|---|---|
| World | 93 | 87 |
| Africa | 26 | 22 |
| Americas | 25 | 25 |
| Eastern Mediterranean | 0 | 0 |
| Europe | 36 | 33 |
| South-East Asia | 4 | 5 |
| Western Pacific | 2 | 2 |
SARS-CoV-2 variant circulation: Last 28 days
WHO is currently tracking several SARS-CoV-2 variants:
- Variants of Interest: JN.1
- Variants Under Monitoring: LP.8.1, NB.1.8.1, XFG, XEC, KP.3.1.1, and KP.3
The most prevalent variant, LP.8.1, accounted for 26% of all submitted sequences in the week ending on 15 June 2025 which is a decrease from 28% in the week ending on 18 May 2025. NB.1.8.1 accounted for 24% of all submitted sequences in the week ending on 15 June 2025, a slight increase from 23% in the week ending on 18 May 2025. XFG accounted for 19% of all submitted sequences in the week ending on 15 June 2025, a significant increase from 10% in the week ending on 18 May 2025 (Table 3).
During this reporting period, all other variants showed a decreasing or stable trend. Available evidence suggests that LP.8.1, NB.1.8.1, and XFG do not pose additional public health risks relative to other currently circulating SARS-CoV-2 variants. Due to proportionally low detections (less than 1%) for consecutive weeks, LB.1 has been deescalated from being a VUM.
At the regional level, in the week ending on 15 June 2025 compared to the week ending on 18 May 2025, LP.8.1 declined in the European Region, the Western Pacific Region, and the Americas, which were the regions with sufficient data. NB.1.8.1 declined in the Americas but increased in the European Region and the Western Pacific Region. XFG increased in all regions with sufficient data. Additionally KP.3.1.1 increased in the Western Pacific Region and JN.1 increased in the Americas.
Country level details are available in | Circulation section
Information on WHO variant monitoring is available in | Variant section
Table 3. Weekly prevalence of SARS-CoV-2 VOIs and VUMs
| Variant | Variant type | 18 May 2025 | 25 May 2025 | 1 Jun 2025 | 8 Jun 2025 | 15 Jun 2025 |
|---|---|---|---|---|---|---|
| JN.1 | VOI | 12.4 | 14.6 | 15 | 12.1 | 12.4 |
| KP.3 | ||||||
| VUM | 1.51 | 2.02 | 1.4 | 1.22 | 1.32 | |
| KP.3.1.1 | ||||||
| VUM | 5.11 | 4.87 | 4.67 | 3.39 | 3.7 | |
| LP.8.1 | ||||||
| VUM | 28.1 | 27.2 | 21.9 | 24.9 | 25.7 | |
| NB.1.8.1 | ||||||
| VUM | 23.5 | 23.7 | 23.9 | 26.1 | 23.8 | |
| XEC | ||||||
| VUM | 11.7 | 7.94 | 6.61 | 5.69 | 6.08 | |
| XFG | ||||||
| VUM | 10.2 | 13.2 | 19.4 | 20.3 | 19.1 |
Inga kommentarer:
Skicka en kommentar